1-3 of 3
Tammy Schuler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Andrew Artz, Brent R. Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy Schuler, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 109.
https://doi.org/10.1182/blood-2023-173855
Published: 2023
Journal Articles

Real-World Use of Ruxolitinib in Patients with Myelofibrosis Who Had Anemia or Thrombocytopenia at US Community Practices

Srdan Verstovsek, Jingbo Yu, Emily Bland, Tammy Schuler, Thomas Cordaro, Evan Braunstein
Journal: Blood
Blood (2022) 140 (Supplement 1): 8131–8132.
https://doi.org/10.1182/blood-2022-169426
Published: 2022
Journal Articles

The Use of Fedratinib for Myelofibrosis As a Potential Bridge to Hematopoietic Stem Cell Transplantation after Ruxolitinib Failure: Real-World Assessment of Treatment Characteristics and Spleen, Symptom, and Hematologic Response

John Mascarenhas, Claire Harrison, Tammy Schuler, Djibril Liassou, Marné Garretson, Sankar Mahadevan, Ali McBride, Derek Tang, Irene S. DeGutis, Pranav Abraham, Aaron T. Gerds
Journal: Blood
Blood (2022) 140 (Supplement 1): 5276–5278.
https://doi.org/10.1182/blood-2022-156780
Published: 2022